Results for
""Estrogen Antagonists""[mesh_terms]

Breast cancer prevention with anti-estrogens: review of the current evidence and future directions.

Supriya Mallick, Rony Benson, P K Julka

Breast cancer (Tokyo, Japan) 2016;23(2):170-7

Autophagy and endocrine resistance in breast cancer.

Katherine L Cook, Ayesha N Shajahan, Robert Clarke

Expert review of anticancer therapy 2012;11(8):1283-94

Danazol for heavy menstrual bleeding.

H Beaumont, C Augood, K Duckitt, A Lethaby

The Cochrane database of systematic reviews 2002

Danazol for heavy menstrual bleeding.

H Beaumont, C Augood, K Duckitt, A Lethaby

The Cochrane database of systematic reviews 2007;2007(3):CD001017

Multiple-targeting and conformational selection in the estrogen receptor: computation and experiment.

Peng Yuan, Kaiwei Liang, Buyong Ma, Nan Zheng, Ruth Nussinov, Jian Huang

Chemical biology & drug design 2011;78(1):137-49

Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.

Gábor Széplaki, Lilian Varga, Szilvia Valentin, Mónika Kleiber, István Karádi, László Romics, George Füst, Henriette Farkas

The Journal of allergy and clinical immunology 2005;115(4):864-9

Adherence rates and correlates in long-term hormonal therapy.

Julia Dunn, Carolyn Gotay

Vitamins and hormones 2013;93():353-75

Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data.

David F Archer, Corrado Altomare, Wei Jiang, Susannah Cort

Menopause (New York, N.Y.) 2018;24(10):1167-1174

Oral therapy for Peyronie's disease.

M Monga, L A Mynderse

International journal of impotence research 2003;14(5):340-4

The estrogen receptor: a model for molecular medicine.

V Craig Jordan, Elwood V Jensen

Clinical cancer research : an official journal of the American Association for Cancer Research 2004;9(6):1980-9

Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity.

T E McAlindon, J Gulin, T Chen, T Klug, R Lahita, M Nuite

Lupus 2002;10(11):779-83

Abarelix: abarelix-depot-F, abarelix-depot-M, abarelix-L, PPI 149, R 3827.

Drugs in R&D 2004;4(3):161-6

Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation.

C Farquhar, J I Beck, C Boothroyd, M Proctor, E Hughes

The Cochrane database of systematic reviews 2005

Marked individual variation in isoflavone metabolism after a soy challenge can modulate the skeletal effect of isoflavones in premenopausal women.

Ho Seok Kwak, Mi Gyeong Kim, Chang Hoon Yim, Hyun Koo Yoon, Ki Ok Han, So Young Park

Journal of Korean medical science 2010;24(5):867-73

Reducing the risk of breast cancer.

R T Chlebowski

The New England journal of medicine 2000;343(3):191-8